×
HOME OUR SERVICES CONSTRUCTION & ENGINEERING LIFE SCIENCES WHY CLIENTS CHOOSE US MANAGEMENT TEAM REGISTER WITH US PODCAST CONTACT US
PODCASTS

Series 3 - Latest Episodes

Series 1 - All Episodes   Series 2 - All Episodes

Series 3 - Episode 9: Jo Bhakdi CEO and Founder of Quantgene- Extending life with Data

This week we speak to Jo Bhakdi Founder and CEO of Quantgene.

Jo and the team at Quantgene are about to launch Serenity, the worlds first medical solution to protect against multiple cancers through early detection and prevention.

Jo combines the perfect blend of economics and science to become a real disrupter in the industry.

In today's episode, we cover

  • Who is Jo Bhakdi and what is his background?
  • What does Quantgene do?
  • Jo's vision is what he calls "10 in 10" to extend the healthy human lifespan by a decade within the next decade.
  • How Quantgene helped the film industry get back on its feet by providing on-site coronavirus testing and results within a 24hrs window.
  • Answers to our quick-fire questions.

Series 3 - Episode 8: Scientist by day and Chef by night with Vidya Maharaj

This week we speak to Vidya Maharaj, Vice president of Clinical Operations and Development at Regenerative Outcomes.

Not only does she have an extremely successful career in pharmaceuticals which has seen her rapidly climb through the ranks. Vidya is also executive Chef at one of Miami's hottest beachfront restaurants. 

Find out how she juggles two extremely successful careers and everything else in between.

Series 3 - Episode 7: Non-Invasive detection and diagnosis of breast cancer with Elizabeth Cormier-May

Radically improving the detection, diagnosis and treatment of women's health-related disease.

Elizabeth Cormier-May and the team Mammogen are integrating data, science and the lived experiences from patients that they serve into the ongoing product development efforts related to their flagship breast cancer program.

Mammogen is a female-led biotechnology company focused on meaningfully improving the detection, diagnosis and treatment of women's health-related diseases, and creating an end-to-never-end community for women around the world.

Mammogen is centred around its proprietary genTRU™ liquid biopsy platform. The company's flagship genTRU breast™ program leverages novel messenger RNA (mRNA) technology to non-invasively detect and diagnose breast cancer.

Mammogen's core technology is a non-invasive screening solution intended for all women, but particularly for the under-40 population who aren't eligible for annual mammography and the 55+ population who are only recommended for mammography every other year.

Series 3 - Episode 6: Supporting the Rare Disease community with Alex Evans, CEO at RAREiTi

With a background in nursing as well as in the pharmaceutical industry, Alex Evans​ brings a wealth of experience and expertise to her role as CEO of RAREiTi.

Tune in to hear how their managed access and medicines management programs offer support beyond therapy, combining care solutions that are specifically developed, carefully measured, and designed to improve outcomes. 

There's tremendous potential here to help rare disease drug developers increase their success rates locally and globally, and at the same time help doctors and patients gain access to new, and often life-changing, medicines.

A heart-warming episode with stories of patients this amazing resource has helped.

Series 3 - Episode 5: Addressing the unmet needs of the life sciences sector - Alethea Wieland

Alethea Wieland is the President and Founder of Clinical Research Strategies based in Pittsburgh.

A boutique CRO and an executive management consultancy addressing a lot of the unmet needs for the Life Sciences Sector.

Alethea and her husband founded the company 10 years ago and have over 70 years of experience between them.

Through embracing the ever-changing legislations Altehea a regulatory Scientist by training is watching where the work is going and successfully winning it.

Althea and her team have been working on novel products that the FDA have never seen before from software to medical devices, federated medicine, new biologics and even a cannabis product.

With a solid foundation in Regulatory science, Alethea is focused on putting the right fit for purpose team together for her clients. The sky really is the limit for Clinical Research Strategies so make sure you tune in to hear more.

Series 3 - Episode 4: Paul Simms "Pharma Provocateur" and CEO of Impatient health

This week we hear from "Pharma Provocateur" and CEO of Impatient Health, Paul Simms.

Paul set up Impatient health in May 2020 to challenge the Status Quo and help companies within the industry stand out from the crowd. He believes "now is the age of experimentation".

We hear how Paul is looking to drive Innovative conversations forward and isn't afraid to break a few eggs in the process.

Paul shares some thought-provoking views and his predictions for the future of Pharma.

Click the link below to connect with Paul Simms:

https://www.linkedin.com/in/psimms/

Series 3 - Episode 3: Brazen Bio helping biotech founders improve human health!

This week we speak to the Founders of Brazen Bio about their 12-week Incubator program, which is set to help potential biotech founders launch their company and prove their concepts.

After quitting his neurosurgery residency Shawn Carbonell, MD, PhD founded his first biotech startup a decade ago. This saw him see how gruelling and brutal starting a biotech can be, so he vowed to one day do something to help others translate their science into medicines. Shawn has successfully invented and developed a cancer drug that is currently in phase 1 clinical trial.

Brent Witgen, PhD, has worked in big pharma for the past decade, building high performing biotech teams in the US, EU and Asia. Brent has had direct involvement in over a dozen drug and device regulatory filings across multiple areas of human disease.

Brent and Shawn have now teamed up to launch Brazen Bio to help biotech founders advance human health. Through Brazens turnkey incubator program, start-ups will have access to state-of-the-art labs, full access to $1.5M worth of equipment, including lab reagents and consumables. And as if that wasn't enough, accommodation, flights, food, and an M1 MacBook, amongst other benefits, will be included.

Based in LA this is a great opportunity to be involved with the first cohort of founders through the program this year.

Click the links below to connect to Brazen Bio

 

https://wefunder.com/brazenbio/

https://www.linkedin.com/company/brazenbio/

https://www.brazen.bio

Series 3 - Episode 2: "The Key to life is learning!!" - Dr Ian White, Founder & CSO at Neobiosis

This is something today's guest is very good at. Not only is Dr Ian White an expert in Regenerative Stem cell medicine, Ian has written treasure maps and created real-life treasure hunts.

He's written and submitted a full feature-length sci-fi movie to Hollywood and he's also an avid inventor. It's safe to say not only is Ian a Scientist and Medic, he's an entrepreneur and has a highly creative mind.

His story is fascinating and just when you think he can't have done anymore he shares another amazing story. Today's episode is one not to be missed so sit back and enjoy the show!!!

Series 3 - Episode 1: Leigh Fell reviews the impact of Covid-19 on Mental health and the increase of Neurology studies

Welcome back to Series Three of The Huxley Morton Podcast!

The show where we hear stories from Industry Leaders within the world of Clinical Trials.

This week we kick off Series three with two Episodes.

On the first episode out today, we speak to Leigh Fell CEO of Caritas Neuro Solutions.

Tune in to hear how Leigh started out in the industry having never heard of it before she was in it!

Leigh discusses what made her want to set up her own business and her keen interest in Neuro Science, Mental Health, mind-body medicine and harnessing the power of placebo to enhance pharmaceutical therapies.

Huxley Morton
© 2020 - Huxley Morton